Quality of life in patients with severe aortic stenosis undergoing transcatheter aortic valve implantation: tools and evidence.

IF 2.9 3区 医学 Q2 CARDIAC & CARDIOVASCULAR SYSTEMS
Journal of Cardiovascular Medicine Pub Date : 2024-04-01 Epub Date: 2024-03-01 DOI:10.2459/JCM.0000000000001591
Marco Metra, Crina-Ioana Radulescu, Angelica Cersosimo, Mauro Massussi, Andrea Laurito, Ovidiu Chioncel, Marianna Adamo
{"title":"Quality of life in patients with severe aortic stenosis undergoing transcatheter aortic valve implantation: tools and evidence.","authors":"Marco Metra, Crina-Ioana Radulescu, Angelica Cersosimo, Mauro Massussi, Andrea Laurito, Ovidiu Chioncel, Marianna Adamo","doi":"10.2459/JCM.0000000000001591","DOIUrl":null,"url":null,"abstract":"<p><p>Aortic stenosis is the most prevalent valvular heart disease requiring intervention, especially in the elderly population. Surgical aortic valve replacement and transcatheter aortic valve implantation (TAVI) are well established treatment options for symptomatic patients with severe aortic stenosis, as they provide a significant survival benefit. Aortic stenosis may have an important impact on patients' quality of life (QoL). However, advanced age, comorbidities and frailty may limit the beneficial effect of aortic stenosis interventions in terms of QoL. Current guidelines mention the importance of frailty and avoiding the futility of interventions, but lack specific indications about decision-making. Also, there are limited data on how to specifically assess QoL in aortic stenosis patients since the most used questionnaires are validated in different populations (i.e. heart failure). The aim of this review is to summarize all the available tools for QoL assessment in patients with aortic stenosis; to report current evidence on the impact of TAVI on QoL; and to discuss the role of frailty and comorbidities in this setting.</p>","PeriodicalId":15228,"journal":{"name":"Journal of Cardiovascular Medicine","volume":"25 4","pages":"259-270"},"PeriodicalIF":2.9000,"publicationDate":"2024-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Cardiovascular Medicine","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.2459/JCM.0000000000001591","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/3/1 0:00:00","PubModel":"Epub","JCR":"Q2","JCRName":"CARDIAC & CARDIOVASCULAR SYSTEMS","Score":null,"Total":0}
引用次数: 0

Abstract

Aortic stenosis is the most prevalent valvular heart disease requiring intervention, especially in the elderly population. Surgical aortic valve replacement and transcatheter aortic valve implantation (TAVI) are well established treatment options for symptomatic patients with severe aortic stenosis, as they provide a significant survival benefit. Aortic stenosis may have an important impact on patients' quality of life (QoL). However, advanced age, comorbidities and frailty may limit the beneficial effect of aortic stenosis interventions in terms of QoL. Current guidelines mention the importance of frailty and avoiding the futility of interventions, but lack specific indications about decision-making. Also, there are limited data on how to specifically assess QoL in aortic stenosis patients since the most used questionnaires are validated in different populations (i.e. heart failure). The aim of this review is to summarize all the available tools for QoL assessment in patients with aortic stenosis; to report current evidence on the impact of TAVI on QoL; and to discuss the role of frailty and comorbidities in this setting.

接受经导管主动脉瓣植入术的重度主动脉瓣狭窄患者的生活质量:工具与证据。
主动脉瓣狭窄是最常见的需要干预的瓣膜性心脏病,尤其是在老年人群中。手术主动脉瓣置换术和经导管主动脉瓣植入术(TAVI)是治疗有症状的重度主动脉瓣狭窄患者的成熟治疗方案,因为它们能显著提高患者的生存率。主动脉瓣狭窄可能会对患者的生活质量(QoL)产生重要影响。然而,高龄、合并症和体弱可能会限制主动脉瓣狭窄干预对生活质量的有益影响。目前的指南提到了体弱和避免干预无效的重要性,但缺乏关于决策的具体说明。此外,关于如何具体评估主动脉瓣狭窄患者 QoL 的数据也很有限,因为最常用的调查问卷已在不同人群(如心力衰竭)中得到验证。本综述旨在总结用于评估主动脉瓣狭窄患者 QoL 的所有可用工具;报告 TAVI 对 QoL 影响的现有证据;讨论虚弱和合并症在这种情况下的作用。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Journal of Cardiovascular Medicine
Journal of Cardiovascular Medicine 医学-心血管系统
CiteScore
3.90
自引率
26.70%
发文量
189
审稿时长
6-12 weeks
期刊介绍: Journal of Cardiovascular Medicine is a monthly publication of the Italian Federation of Cardiology. It publishes original research articles, epidemiological studies, new methodological clinical approaches, case reports, design and goals of clinical trials, review articles, points of view, editorials and Images in cardiovascular medicine. Submitted articles undergo a preliminary review by the editor. Some articles may be returned to authors without further consideration. Those being considered for publication will undergo further assessment and peer-review by the editors and those invited to do so from a reviewer pool. ​
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信